QQQ   386.76 (-0.14%)
AAPL   193.02 (-0.21%)
MSFT   369.81 (-0.73%)
META   320.44 (+0.68%)
GOOGL   130.75 (-0.18%)
AMZN   145.62 (-0.86%)
TSLA   244.83 (+2.56%)
NVDA   464.32 (-0.29%)
NIO   8.10 (+9.02%)
BABA   72.17 (-0.29%)
AMD   119.33 (+0.80%)
T   16.96 (-1.51%)
F   10.79 (+1.79%)
MU   73.89 (+0.27%)
CGC   0.68 (+2.73%)
GE   120.47 (+0.20%)
DIS   92.15 (+1.50%)
AMC   6.95 (-1.00%)
PFE   29.21 (+0.41%)
PYPL   60.10 (+3.76%)
XOM   99.23 (-1.20%)
QQQ   386.76 (-0.14%)
AAPL   193.02 (-0.21%)
MSFT   369.81 (-0.73%)
META   320.44 (+0.68%)
GOOGL   130.75 (-0.18%)
AMZN   145.62 (-0.86%)
TSLA   244.83 (+2.56%)
NVDA   464.32 (-0.29%)
NIO   8.10 (+9.02%)
BABA   72.17 (-0.29%)
AMD   119.33 (+0.80%)
T   16.96 (-1.51%)
F   10.79 (+1.79%)
MU   73.89 (+0.27%)
CGC   0.68 (+2.73%)
GE   120.47 (+0.20%)
DIS   92.15 (+1.50%)
AMC   6.95 (-1.00%)
PFE   29.21 (+0.41%)
PYPL   60.10 (+3.76%)
XOM   99.23 (-1.20%)
QQQ   386.76 (-0.14%)
AAPL   193.02 (-0.21%)
MSFT   369.81 (-0.73%)
META   320.44 (+0.68%)
GOOGL   130.75 (-0.18%)
AMZN   145.62 (-0.86%)
TSLA   244.83 (+2.56%)
NVDA   464.32 (-0.29%)
NIO   8.10 (+9.02%)
BABA   72.17 (-0.29%)
AMD   119.33 (+0.80%)
T   16.96 (-1.51%)
F   10.79 (+1.79%)
MU   73.89 (+0.27%)
CGC   0.68 (+2.73%)
GE   120.47 (+0.20%)
DIS   92.15 (+1.50%)
AMC   6.95 (-1.00%)
PFE   29.21 (+0.41%)
PYPL   60.10 (+3.76%)
XOM   99.23 (-1.20%)
QQQ   386.76 (-0.14%)
AAPL   193.02 (-0.21%)
MSFT   369.81 (-0.73%)
META   320.44 (+0.68%)
GOOGL   130.75 (-0.18%)
AMZN   145.62 (-0.86%)
TSLA   244.83 (+2.56%)
NVDA   464.32 (-0.29%)
NIO   8.10 (+9.02%)
BABA   72.17 (-0.29%)
AMD   119.33 (+0.80%)
T   16.96 (-1.51%)
F   10.79 (+1.79%)
MU   73.89 (+0.27%)
CGC   0.68 (+2.73%)
GE   120.47 (+0.20%)
DIS   92.15 (+1.50%)
AMC   6.95 (-1.00%)
PFE   29.21 (+0.41%)
PYPL   60.10 (+3.76%)
XOM   99.23 (-1.20%)

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Price, News & Analysis (NASDAQ:HROWM)

$25.20
+0.06 (+0.24%)
(As of 11:39 AM ET)
Compare
Today's Range
$25.20
$25.39
50-Day Range
$23.60
$25.97
52-Week Range
$22.71
$26.50
Volume
2,002 shs
Average Volume
12,043 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. its products portfolio includes topical eye drop drug candidates, including surf-100 and surf-200; surf-300, an oral capsule for treating patients suffering from ocular surface diseases, and ded signs and symptoms; klarity drops to protect and rehabilitate the ocular surface pathology for patients with ded; melt-100, a drug that is administered sublingually for conscious sedation during cataract surgery; may-66 that is used for the treatment of symptoms associated with peyronie's diseas

HROWM Stock Price History

HROWM Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive HROWM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Harrow Health, Inc. 11.875% Senior Notes due 2027 and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/31 Dividend
10/12/2023
Dividend Payable
10/31/2023
Today
12/06/2023

Industry, Sector and Symbol

Industry
- -
Sub-Industry
N/A
Sector
--
Current Symbol
NASDAQ:HROWM
Web
N/A
Phone
N/A
Fax
N/A
Employees
125
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report














HROWM Stock Analysis - Frequently Asked Questions

How have HROWM shares performed in 2023?

Harrow Health, Inc. 11.875% Senior Notes due 2027's stock was trading at $25.23 on January 1st, 2023. Since then, HROWM shares have increased by 0.6% and is now trading at $25.39.
View the best growth stocks for 2023 here
.

Are investors shorting Harrow Health, Inc. 11.875% Senior Notes due 2027?

Harrow Health, Inc. 11.875% Senior Notes due 2027 saw a decline in short interest in November. As of November 15th, there was short interest totaling 500 shares, a decline of 28.6% from the October 31st total of 700 shares. Based on an average daily trading volume, of 7,100 shares, the days-to-cover ratio is currently 0.1 days.
View Harrow Health, Inc. 11.875% Senior Notes due 2027's Short Interest
.

How often does Harrow Health, Inc. 11.875% Senior Notes due 2027 pay dividends? What is the dividend yield for Harrow Health, Inc. 11.875% Senior Notes due 2027?

Harrow Health, Inc. 11.875% Senior Notes due 2027 declared a quarterly dividend on Thursday, October 12th. Stockholders of record on Sunday, October 15th will be paid a dividend of $0.7422 per share on Tuesday, October 31st. This represents a $2.97 dividend on an annualized basis and a dividend yield of 11.69%. The ex-dividend date is Thursday, October 12th.
Read our dividend analysis for HROWM
.

How do I buy shares of Harrow Health, Inc. 11.875% Senior Notes due 2027?

Shares of HROWM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:HROWM) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -